However, in December 2004 the United States the 14-member Food and Drug Administration (FDA) advisory committee, plus voting consultants, for Reproductive Health Drugs unanimously rejected Procter and Gamble's fast-track request for Intrinsa citing concerns about off-label use . In Canada, post-menopausal women have been able to obtain government-approved testosterone treatment since 2002. In Australia, post-menopausal women can use Organon testosterone implants which have to be surgically inserted and last from three to six months. 
Anti-epileptic medication (AED)
How do AEDs work?
Which drug is right for me?
Getting the dosage right
What about side effects?
Women and anti-epileptic medication
Emergency drug treatment
Stopping anti-epileptic medication
Vagus/Vagal Nerve Stimulation (VNS)
And finally …. medical research